行情

NTRA

NTRA

Natera
NASDAQ

实时行情|Nasdaq Last Sale

31.30
+1.52
+5.10%
盘后: 31.30 0 0.00% 16:00 04/08 EDT
开盘
30.21
昨收
29.78
最高
31.54
最低
29.62
成交量
73.50万
成交额
--
52周最高
41.80
52周最低
16.87
市值
24.49亿
市盈率(TTM)
-17.3378
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测NTRA价格均价为42.00,最高价位49.00,最低价为32.00。

EPS

NTRA 新闻

更多
  • 美联储用紧急降息争取时间 同时着眼推出新工具
  • 新浪美股 · 46分钟前
  • 外盘头条:美联储纪要称维持零利率直至消化疫情打击
  • 新浪美股 · 1小时前
  • 工作中使用WhatsApp?摩根大通解雇了这名高级交易员
  • 新浪美股 · 1小时前
  • 减产传言不断 标普在能源股推动下进入"技术性牛市"
  • 新浪美股 · 1小时前

所属板块

医疗设备、用品及经销
+4.21%
医疗设备和用品
+4.01%

热门股票

代码
价格
涨跌幅

NTRA 简况

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).
展开

微牛提供Natera Inc(NASDAQ-NTRA)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NTRA股票新闻,以帮助您做出投资决策。